Cytokinetics, Incorporated Reports Third Quarter 2010 Financial Results – msnbc.com

Posted on November 1, 2010 by admin

Moving forward, we are readying for the initiation of a third Evidence of Effect trial in patients with myasthenia gravis,” stated Robert I. Blum, President and Chief Executive Officer of Cytokinetics. “Data from these trials appear consistent with our … Bing News – Full Story →

Share

Related posts:

  1. Chelsea Therapeutics to Host Conference Call to Discuss Third Quarter 2010 Results – msnbc.com
  2. ResMed Announces Conference Call and Webcast to Discuss First Quarter 2011 Results – Yahoo Finance
  3. Chelsea Therapeutics to Present at 2010 Newsmakers in the Biotechnology Industry Conference – msnbc.com
  4. Ora CEO Addresses Complexities of Dry Eye Clinical Research at TFOS Conference in Florence, Italy – msnbc.com
  5. Gene Therapy That Works in Mice Could Make Humans Happy – msnbc.com
This entry was posted in Myasthenia Gravis and tagged , , , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>